A groundbreaking gene therapy proven successful in treating an inherited, blinding eye disease in dogs is now poised for clinical trials in humans with the rare condition retinitis pigmentosa. The therapy, which halts vision loss by introducing a normal copy of the CNGB1 gene, could potentially benefit around 2 million people affected worldwide.
from Neuroscience News https://ift.tt/MKsre7E
from Neuroscience News https://ift.tt/MKsre7E
Comments
Post a Comment